BioCanRx Targeted Funding – Clinical, Social and Economic Impact Program
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit:
Memorial Deadline: Inquire with RGCS
External Deadline: Wednesday 1st, November 2017
Description
BioCanRx is pleased to announce that the next call for applications is now open in the Clinical, Social & Economic Impact (CSEI) program. At this time, BioCanRx is placing highest priority on the intake of new applications for funding, in the area of development and application of early Health Technology Assessment (HTA) tools and measures, to apply to phase I Clinical Trial applications or funded projects in the BioCanRx technology portfolio. Of important note, these CSEI program applications will be expected to speak very specifically to the value-add of the proposed research deliverables on the successful forward development of BioCanRx technologies, the impact of the intended research deliverables on their later stage adoption, regulatory approval, and/or health system payer decisions or policies.
BioCanRx expects that applications received in this funding call may be of pilot scale, such that successful outcomes of funded research may inform a follow-on larger implementation project or program within BioCanRx’s next funding cycle. Applicants will be expected to speak to how research conducted in this funding round will inform later stage and larger scale implementation of research outcomes.
-
-
- Available Budget: $100k/project.
-
Funding timelines: applicants should be aware that all projects must plan to be completed no later than March 31, 2020. The anticipated start date of projects awarded in this funding cycle is April 1, 2018.
Connecting with BioCanRx: As this Call for Proposals is seeking research directly applicable to the BioCanRx technology portfolio (view our funded projects here: https://biocanrx.com/research/project-portfolio/clinical-trials), please contact Drs. Kelley Parato (keparato@biocanrx.com), Stéphanie Michaud (smichaud@biocanrx.com), or John Bell (jbell@ohri.ca) at any time to connect with any of our Network’s technology experts or project leaders, to collaborate in the development of your submission.
Application deadlines: LOI submission deadline will be 11:59 am EST on November 1, 2017. Invited full applications are anticipated by mid-February 2018 (date TBD) for funding to commence by April 1, 2018.
Additional program guidelines are available on BioCanRx’s website.